Target intelligence / Profile preview

Bisacodyl

Molecular classification
Other (Small molecule drug), Other (Diphenylmethane derivative)
01

Overview

Bisacodyl is a synthetic diphenylmethane derivative stimulant laxative used to treat constipation and to prepare the bowel for medical procedures. It acts locally on the large intestine by stimulating enteric nerves, increasing peristaltic contractions, and enhancing fluid and electrolyte secretion, resulting in bowel evacuation. Its effects appear within 6–12 hours of oral dosing or within one hour of rectal administration. Although it has been widely used since the 1950s, bisacodyl is classified strictly as a small molecule drug and is not a molecular target such as a receptor or enzyme[2][3][5][8][10].

Other names
bisacodilDulcolaxLA96AneolaxivilaxLaxans(Pyridin-2-ylmethylene)bis(4,1-phenylene) diacetateBicollaco
02

Mechanism of action

Direct stimulation of colonic mucosa sensory nerve endings to induce peristalsis (prokinetic action) Increase in water and electrolyte secretion into the intestines Metabolized by hydrolysis to active forms in the bowel May involve modulation of colonic potassium channels

03

Biological functions

Other (Exerts pharmacological effect by stimulating peristalsis and fluid secretion in the colon)
04

Disease associations

Other (Treatment of constipation, bowel evacuation for procedures)
05

Safety considerations

Abdominal cramps/discomfortDiarrheaElectrolyte imbalance (especially with prolonged use)Potential for dependence with chronic useContraindicated in intestinal obstruction, severe dehydration, or acute abdominal conditions
06

Biomarkers

None specific; no established biomarkers for bisacodyl patient selection or monitoring.

Beyond the preview

Go deeper on Bisacodyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bisacodyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call